Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine

Neuroscience

Volumn 114, Issue 4, 2002, Pages 925-933

  Lin, D ^a,b   Bruijnzeel, A W ^a   Schmidt, P ^a   Markou, A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ARENA PHARMACEUTICALS   (United States)

Author keywords

Amphetamine; Brain stimulation reward; Drug addiction; Intracranial self stimulation; Rat

Indexed keywords

AMPHETAMINE; PSYCHOSTIMULANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG WITHDRAWAL; LATENT PERIOD; LATERAL HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SELF STIMULATION; STRESS; WEIGHT REDUCTION;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC DISEASE; FOOD DEPRIVATION; HYPOTHALAMIC AREA, LATERAL; MALE; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; REWARD; SELF STIMULATION; STRESS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036837171     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00366-4     Document Type: Article

References (58)

1. Abrahamsen G.C., Berman Y., Carr K.D. Curve-shift analysis of self-stimulation in food-restricted rats: relationship between daily meal, plasma corticosterone and reward sensitization. Brain Res. 695:1995;186-194.
2. Akiskal H.S., McKinney W.T. Jr. Depressive disorders: toward a unified hypothesis. Science. 182:1973;20-29.
3. American Psychiatric Association, 1994. Diagnostic and statistical manual of mental disorders IV. American Psychiatric Press, Washington, DC.
4. Anisman, H., 1984. Vulnerability to depression: Contribution of Stress. In: Post, R.M., Ballenger, J. (Eds.), Frontiers of Clinical Neuroscience, Vol. 1. Williams and Wilkins, Baltimore, MD, pp. 407-431.
5. Anisman H., Zacharko R.M. Depression: The predisposing influence of stress. Behav. Brain Sci. 5:1982;89-137.
6. Barr A.M., Phillips A.G. Chronic mild stress has no effect on responding by rats for sucrose under a progressive ratio schedule. Physiol. Behav. 64:1998;591-597.
7. Caesar P., Collins G., Sandler M. Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats. Biochem. Pharmacol. 19:1970;921-926.
8. Carr K.D., Wolinsky T.D. Chronic food restriction and weight loss produce opioid facilitation of perifornical hypothalamic self-stimulation. Brain Res. 607:1993;141-148.
9. Carroll M.E., Lac S.T., Walker M.J., Kragh R., Newman T. Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation. J. Pharmacol. Exp. Ther. 238:1986;1-7.
10. Engen, T., 1971. Psychophysics. In: Kling, J.W., Riggs, L.A. (Eds.) Woodworth and Schlosberg's Experimental Psychology. Holt Rinehart and Winston, New York, pp. 11-46.
11. Epping-Jordan M.P., Watkins S.S., Koob G.F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 393:1998;76-79.
12. Esposito R.U., Perry W., Kornetsky C. Effects of D-amphetamine and naloxone on brain stimulation reward. Psychopharmacology. 69:1980;187-191.
13. Figlewicz D.P., Woods S.C. Adiposity signals and brain reward mechanisms. Trends Pharmacol. Sci. 7:2000;235-236.
14. Fulton S., Woodside B., Shizgal P. Modulation of brain reward circuitry by leptin. Science. 287:2000;125-128.
15. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
16. Gilad G.M., Rabey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 40:1987;2401-2408.
17. Haney M., Maccari S., Le Moal M., Simon H., Piazza P.V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res. 698:1995;46-52.
18. Hunt G.E., Atrens D.M., Jackson D.M. Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation. Pharmacol. Biochem. Behav. 48:1994;853-862.
19. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
20. Kamata K., Yoshida S., Kameyama T. Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine. Brain Res. 371:1986;197-200.
21. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16:1982;965-968.
22. Kendler K.S., Kessler R.C., Walters E.E., Maclean C., Neale M.C., Heath A.C., Eaves L.J. Stressful life events, genetic liability and onset of an episode of major depression in women. Am. J. Psychiatry. 152:1995;833-842.
23. Kessler R. The effects of stressful life events on depression. Annu. Rev. Psychol. 48:1997;191-214.
24. Koob G. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
25. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
26. Kornetsky C., Esposito R.U. Euphorigenic drugs: effects on the reward pathways of the brain. Fed. Proc. 38:1979;2473-2476.
27. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51:1998;23-47.
28. Lin D., Koob G.F., Markou A. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat - interactions between the two drugs. Psychopharmacology (Berl.). 145:1999;283-294.
29. Mantsch J.R., Saphier D., Goeders N.E. Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. J. Pharmacol. Exp. Ther. 287:1998;72-80.
30. Markou A., Koob G.F. Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology. 4:1991;17-26.
31. Markou A., Koob G.F. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology. 7:1992;213-224.
32. Matthews K., Forbes N., Reid I.C. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol. Behav. 57:1995;241-248.
33. Moreau J.L., Bos M., Jenck F., Martin J.R., Mortas P., Wichmann J. 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur. Neuropsychopharmacol. 6:1996;169-175.
34. Moreau J.L., Bourson A., Jenck F., Martin J.R., Mortas P. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J. Psychiatry Neurosci. 19:1994;51-56.
35. Moreau J.L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2:1992;43-49.
36. Muscat R., Papp M., Willner P. Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol. Psychiatry. 31:1992;937-946.
37. Nielsen C.K., Arnt J., Sanchez C. Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences. Behav. Brain Res. 107:2000;21-33.
38. Ortiz J., De Caprio J.L., Kosten T.A., Nestler E.J. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience. 67:1995;383-397.
39. Papp M., Willner P., Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology. 104:1991;255-259.
40. Paterson N.E., Myers C., Markou A. Effects of repeated withdrawal from continuous amphetamine adminstration on brain reward function in rats. Psychopharmacology. 152:2000;440-446.
41. Pelligrino, L., Pelligrino, A., Cushman, A., 1979. A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York.
42. Piazza P.V., Deminiere J.M., LeMoal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
43. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopamineric neurons. Annu. Rev. Pharmacol. Toxicol. 36:1996;359-378.
44. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19:1998;67-74.
45. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA. 88:1991;2088-2092.
46. Platt J.E., Stone E.A. Chronic restraint stress elicits a positive antidepressant response on the forced swim task. Eur. J. Pharmacol. 82:1982;179-181.
47. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 149:1992;999-1010.
48. Puglisi-Allegra S., Kempf E., Cabib S. Role of genotype in the adaptation of the brain dopamine system to stress. Neurosci. Biobehav. Rev. 14:1990;523-528.
49. Ramsey N.F., Van Ree J.M. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Res. 608:1993;216-222.
50. Rodriguez Echandia E.L., Gonzalez A.S., Cabrera R., Fracchia L.N. A further analysis of behavioral and endocrine effects of unpredictable chronic stress. Physiol. Behav. 43:1988;789-795.
51. Rouge-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 10:1998;3903-3907.
52. Willner P. Animal models as simulations of depression. Trends Pharmacol. Sci. 121:1991;131-136.
53. Wise, R., 1982. Common Neural Basis for Brain Stimulation Reward, Drug Reward, and Food Reward. Haer Institute, Brunswick.
54. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
55. Zacharko R.M., Bowers W.J., Anisman H. Responding for brain stimulation: Stress and desmethylimipramine. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 8:1984;601-606.
56. Zacharko R.M., Bowers W.J., Kelley M.S., Anisman H. Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine. Brain Res. 321:1984;175-179.
57. Zacharko R.M., Lalonde G., Kasian M., Anisman H. Strain-specific effects of inescapable shock on intracranial self-stimulation from the nucleus accumbens. Brain Res. 426:1987;164-168.
58. Zacharko R.M., Bowers W., Prince C., Anisman H. Behavioral alterations following repeated exposure to uncontrollable foot-shock or desmethylimipramine. Soc. Neurosci. Abstr. 9:1983;561.